The base FHIR Specification is a platform specification - a specification on which all sorts of different solutions are built. The specification focuses on defining capabilities, and creating an ecosystem. National standards, vendor consortiums, clinical societies, etc publish "implementation guides" that define how the capabilities defined by the FHIR specification are used in particular data exchanges, or to solve particular problems. Here is a list of some of the implementation guides defined by the FHIR community.
|Base National Specifications|
|US-Core: Base US national implementation guide||USA||CI Build v1.9|
|AU Base: Base Australian national implementation guide||AU||CI Build v1.9|
|DAF: Basic arrangements for accessing meaningful use data from EHR systems||USA||Trial Use v1.0||CI Build v1.9|
|Argonaut: US EHR Vendor agreements for consistent access to EHR Data (consistent with DAF, but a subset of it)||USA||CI Build v1.0|
|HSPC: Builds on Argonaut to make agreements around consistent data (in progress)||USA||Draft v1.7|
|C-CDA on FHIR: US Realm Implementation Guide (IG) addressing the key aspects of Consolidated CDA (C-CDA) required for Meaningful Use (MU). This IG focuses on the clinical document header and narrative constraints necessary for human readability, and references the Data Access Framework (DAF) implementation guide for coded data representation||USA||Ballot v1.8|
|SDC: Defines expectations for sharing of Questionnaires and answers, including mechanisms for automatically populating portions of a questionnaire based on embedded mappings to underlying data elements||USA||Trial Use v1.0||Ballot v1.6|
|SDC-DE: defines expectations for sharing of data elements between registries||USA||Trial Use v1.0||Ballot v1.6|
|USLab: US Realm Laboratory ordering and reporting between ambulatory care setting and the laboratory and laboratory reporting to public health jurisdictions||USA||Trial Use v1.0|
|RCPA: Structure Cancer Reporting Protocols (FHIR adaptation of joint CAP/RCPA protocols)||AU||CI Build v1.9|
|US Meds Maturity Project: promote consistent use of the FHIR pharmacy resources in the US Realm||USA||Draft v1.8|
|Quality Measures / Decision Support|
|QICore: QICore defines a uniform way for quality measurement and decision support knowledge to refer to clinical data. The profiles align as much as possible with DAF and incorporate content from the (Quality Data Model) and the (Virtual Medical Record) specifications||USA||Trial Use v1.0||CI Build v1.9|
To add additional implementation guides, email the FHIR Product Director.